Actively Recruiting
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Led by Stanford University · Updated on 2026-04-07
45
Participants Needed
2
Research Sites
161 weeks
Total Duration
On this page
Sponsors
S
Stanford University
Lead Sponsor
L
LUNGevity Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer. Depending on the location and size of the tumor.
CONDITIONS
Official Title
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically or cytologically confirmed lung cancer including non-small cell or small cell lung cancer planned for definitive fractionated radiation (60-66 Gy) with concurrent systemic therapy
- ECOG performance status of 0 to 2
- Age 18 years or older
- Ability to understand and willing to personally sign informed consent
- Estimated life expectancy of 12 weeks or longer
You will not qualify if you...
- Contraindication to receiving radiotherapy or systemic therapy as determined by treating oncologists
- Age younger than 18 years
- Tumor directly invading major pulmonary arteries, aorta, heart, or proximal bronchial tree
- Diagnosis of interstitial pulmonary fibrosis
- Previous radiation therapy to the thorax resulting in overlapping high dose radiation fields
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Stanford University
Palo Alto, California, United States, 94305
Actively Recruiting
2
Stanford Cancer Center South Bay
San Jose, California, United States, 95124
Actively Recruiting
Research Team
A
Aastha Dubey
CONTACT
S
Sonya Boyd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here